Full Year 2018 BioArctic AB Earnings Call Transcript
Ladies and gentlemen, welcome to the BioArctic Q4 2018 report. Today, I'm pleased to present CEO, Gunilla Osswald; and CFO, Jan Mattsson. (Operator Instructions) Speakers, please begin your meeting.
()-&
Thank you so much, and welcome to the full year report of BioArctic from 2018. I'm Gunilla Osswald, and I'm the CEO of BioArctic, and I will share the presentation here today with our CFO, Jan Mattsson.
Next slide, please. This is our disclaimer, and next slide again, please. So BioArctic is focusing on 3 areas where there is a huge unmet medical need: Alzheimer's disease, Parkinson's disease and complete spinal cord injuries.
In Alzheimer's disease and Parkinson's disease today, there are only symptomatic treatments available and we focus on disease-modifying treatment that will affect the underlying disease. Alzheimer's disease and Parkinson's disease are huge and there is a growing market since the population is getting older and older.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |